OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
March 12, 2024
The Cell Shuttle platform will manufacture cell therapies for its first clinical trials by the end of the year.
The European company has seen its business increase by 47% in North America.
March 11, 2024
The Alliance will receive the NSF Regional Innovation Engines Development Award and $1 million in funding.
March 08, 2024
The facility producer’s new innovation hub will offer manufacturing, life sciences, and infrastructure services.
March 07, 2024
Cellares CEO Fabian Gerlinghaus shares how an automated, closed-production platform with a small footprint can dramatically impact cost savings and scalability for cell and gene therapies.
Webinar Date/Time: Tue, Mar 26, 2024 11:00 AM EDT
March 06, 2024
Webinar Date/Time: Friday, April 5, 2024 at 11amEDT | 10am CDT | 8am PDT
March 04, 2024
March 02, 2024
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.